Strumento inattivo

Azioni Forest Laboratories, Inc.

Azioni

Prezzo di chiusura NYSE
- ^USD	-

17/11/16	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
30/06/14	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest
30/06/14	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results
23/06/14	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)
23/06/14	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development

Aggiungi a una lista 0 selezionato Solo clienti o iscritti possono usare questa funzione Accedi Registrati	Variaz.	Variaz. 5g.	Variaz. 1 anno	Variaz. 3 anni	Capi.($)
ELI LILLY AND COMPANY	+0,11%	+1,71%	+63,52%	+117,61%	1.055 Mrd
JOHNSON & JOHNSON	+0,27%	+0,92%	+51,33%	+73,35%	654 Mrd
ABBVIE INC.	+0,73%	+0,68%	+20,70%	+74,90%	467 Mrd
ROCHE HOLDING AG	-1,36%	-2,58%	+40,20%	+42,33%	348 Mrd
NOVARTIS AG	+1,34%	+4,53%	+23,37%	+29,55%	275 Mrd
ASTRAZENECA PLC	-0,48%	-0,54%	+13,56%	+13,50%	258 Mrd
AMGEN INC.	+0,85%	+6,35%	+53,17%	+54,39%	224 Mrd
GILEAD SCIENCES, INC.	+0,85%	+1,10%	+35,78%	+101,82%	187 Mrd
NOVO NORDISK A/S	-0,30%	-2,98%	-27,62%	-61,28%	171 Mrd
Media	+0,13%	+0,52%	+30,45%	+49,57%	404,26 Mrd
Media ponderata per Capi.	-0,05%	+1,00%	+40,69%	+69,85%